» Authors » E V McCloskey

E V McCloskey

Explore the profile of E V McCloskey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 8234
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaalkhorol M, Johansson H, Avirmed S, Dashtseren A, Bruyere O, Lorentzon M, et al.
Arch Osteoporos . 2025 Feb; 20(1):27. PMID: 39955704
Introduction: FRAX models are frequently requested for countries with little or no data on the incidence of hip fracture. In such circumstances, the development of a surrogate FRAX model is...
2.
Kanis J, Johansson H, Lorentzon M, Harvey N, McCloskey E
Calcif Tissue Int . 2025 Jan; 116(1):22. PMID: 39751843
No abstract available.
3.
Johansson H, Pandey D, Lorentzon M, Harvey N, McCloskey E, Kanis J
Arch Osteoporos . 2024 Nov; 19(1):115. PMID: 39546110
Introduction: FRAX models are frequently requested for countries with little or no data on the incidence of hip fractures. In such circumstances, the development of a surrogate FRAX model is...
4.
Schini M, Johansson H, Harvey N, Lorentzon M, Kanis J, McCloskey E
J Endocrinol Invest . 2023 Oct; 47(3):501-511. PMID: 37874461
FRAX®, a simple-to-use fracture risk calculator, was first released in 2008 and since then has been used increasingly worldwide. By calculating the 10-year probabilities of a major osteoporotic fracture and...
5.
Kanis J, Johansson H, McCloskey E, Liu E, Akesson K, Anderson F, et al.
Osteoporos Int . 2023 Aug; 34(12):2027-2045. PMID: 37566158
Introduction: The aim of this study was to quantify the fracture risk associated with a prior fracture on an international basis and to explore the relationship of this risk with...
6.
Schini M, Bhatia P, Shreef H, Johansson H, Harvey N, Lorentzon M, et al.
Bone . 2022 Dec; 168:116651. PMID: 36574893
The relative contributions of factors such as muscle strength, falls risk and low bone mineral density (BMD) to increased fracture risk in Parkinson's Disease (PD) were examined in an analysis...
7.
Chotiyarnwong P, McCloskey E, Harvey N, Lorentzon M, Prieto-Alhambra D, Abrahamsen B, et al.
Arch Osteoporos . 2022 Jun; 17(1):87. PMID: 35763133
Introduction: The burden of long-term osteoporosis management falls on primary care in most healthcare systems. However, a wide and stable treatment gap exists in many such settings; most of which...
8.
McCloskey E, Chotiyarnwong P, Harvey N, Lorentzon M, Kanis J
Osteoporos Int . 2022 Jun; 33(8):1631-1637. PMID: 35763073
No abstract available.
9.
Vandenput L, Johansson H, McCloskey E, Liu E, Akesson K, Anderson F, et al.
Osteoporos Int . 2022 May; 33(10):2103-2136. PMID: 35639106
Introduction: The availability of the fracture risk assessment tool FRAX® has substantially enhanced the targeting of treatment to those at high risk of fracture with FRAX now incorporated into more...
10.
Javaid M, Harvey N, McCloskey E, Kanis J, Cooper C
Osteoporos Int . 2022 Mar; 33(6):1185-1189. PMID: 35286437
No abstract available.